| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2154826 | Nuclear Medicine and Biology | 2007 | 8 Pages |
Abstract
The 111In-labeled IAC showed an improve tumor targeting kinetics with rapid accumulation and prolonged retention in the αvβ3 receptor-positive tumor. This together with the rapid whole-body clearance pharmacokinetics warrants further studies on this IAC analog for molecular imaging of tumor-induced angiogenic vessels and various malignant human tumors expressing the receptor.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Beom-Su Jang, Esther Lim, Seung Hee Park, In Soo Shin, S. Narasimhan Danthi, In Sook Hwang, Nhat Le, Sarah Yu, Jianwu Xie, King C.P. Li, Jorge A. Carrasquillo, Chang H. Paik,